Bolt Biotherapeutics (BOLT)
(Delayed Data from NSDQ)
$0.79 USD
+0.02 (2.00%)
Updated May 24, 2024 04:00 PM ET
After-Market: $0.78 -0.01 (-1.27%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.54 |
EPS Last Quarter | -0.28 |
Last EPS Surprise | 45.10% |
ABR | 3.00 |
Earnings ESP
|
3.26% |
---|---|
Current Year | -1.40 |
Next Year | -0.89 |
EPS (TTM) | -1.66 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.19M | 1.85M | 8.41M | 5.81M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 1.64M | 2.89M | 12.19M | 12.50M |
Low Estimate | 0.73M | 0.80M | 5.30M | 1.14M |
Year ago Sales | 1.43M | 2.53M | 7.88M | 8.41M |
Year over Year Growth Est. | -17.13% | -27.08% | 6.73% | -30.93% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.54 | -0.43 | -1.40 | -0.89 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.51 | -0.43 | -1.59 | -0.87 |
High Estimate | -0.39 | -0.18 | -1.04 | -0.74 |
Low Estimate | -0.66 | -0.65 | -1.76 | -1.09 |
Year ago EPS | -0.48 | -0.43 | -1.83 | -1.40 |
Year over Year Growth Est. | -12.50% | 0.00% | 23.50% | 36.96% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 2 | 3 | 2 |
Up Last 60 Days | 0 | 2 | 4 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 0 | 0 | 1 |
Down Last 60 Days | 2 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.54 | -0.43 | -1.40 | -0.89 |
7 Days Ago | -0.54 | -0.43 | -1.40 | -0.89 |
30 Days Ago | -0.53 | -0.54 | -1.68 | -1.07 |
60 Days Ago | -0.51 | -0.48 | -1.81 | -1.32 |
90 Days Ago | NA | NA | -1.75 | -1.38 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.52 | -0.36 | -1.46 | -0.90 |
Zacks Consensus Estimate | -0.54 | -0.43 | -1.40 | -0.89 |
Earnings ESP | 3.26% | 17.05% | -4.34% | -1.70% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.28 | -0.47 | -0.43 | -0.48 | NA |
Estimate | -0.51 | -0.47 | -0.49 | -0.53 | NA |
Difference | 0.23 | 0.00 | 0.06 | 0.05 | 0.09 |
Surprise | 45.10% | 0.00% | 12.24% | 9.43% | 16.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more